Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.

Kirihara T, Taniguchi T, Yamamura K, Iwamura R, Yoneda K, Odani-Kawabata N, Shimazaki A, Matsugi T, Shams N, Zhang JZ.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):145-153. doi: 10.1167/iovs.17-22745.

PMID:
29332128
2.

Oxidative Stress in Retinal Diseases.

Nishimura Y, Hara H, Kondo M, Hong S, Matsugi T.

Oxid Med Cell Longev. 2017;2017:4076518. doi: 10.1155/2017/4076518. Epub 2017 Mar 15. No abstract available.

3.

Correction to: 'Violence in the prehistoric period of Japan: the spatio-temporal pattern of skeletal evidence for violence in the Jomon period'.

Nakao H, Tamura K, Arimatsu Y, Nakagawa T, Matsumoto N, Matsugi T.

Biol Lett. 2016 Nov;12(11). pii: 20160847. No abstract available.

4.

Violence in the prehistoric period of Japan: the spatio-temporal pattern of skeletal evidence for violence in the Jomon period.

Nakao H, Tamura K, Arimatsu Y, Nakagawa T, Matsumoto N, Matsugi T.

Biol Lett. 2016 Mar;12(3):20160028. doi: 10.1098/rsbl.2016.0028. Erratum in: Biol Lett. 2016 Nov;12 (11):null.

5.

High-performance olefin polymerization catalysts discovered on the basis of a new catalyst design concept.

Matsugi T, Fujita T.

Chem Soc Rev. 2008 Jun;37(6):1264-77. doi: 10.1039/b708843b. Epub 2008 Mar 17.

PMID:
18497937
6.

Effects of the new ethacrynic acid oxime derivative SA12590 on intraocular pressure in cats and monkeys.

Shimazaki A, Kirihara T, Rao PV, Tajima H, Matsugi T, Epstein DL.

Biol Pharm Bull. 2007 Aug;30(8):1445-9.

7.

Effects of bunazosin hydrochloride on ciliary muscle constriction and matrix metalloproteinase activities.

Akaishi T, Takagi Y, Matsugi T, Ishida N, Hara H, Kashiwagi K.

J Glaucoma. 2004 Aug;13(4):312-8.

PMID:
15226660
8.

New ethacrynic acid derivatives as potent cytoskeletal modulators in trabecular meshwork cells.

Shimazaki A, Suhara H, Ichikawa M, Matsugi T, Konomi K, Takagi Y, Hara H, Rao PV, Epstein DL.

Biol Pharm Bull. 2004 Jun;27(6):846-50.

9.

Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.

Takagi Y, Nakajima T, Shimazaki A, Kageyama M, Matsugi T, Matsumura Y, Gabelt BT, Kaufman PL, Hara H.

Exp Eye Res. 2004 Apr;78(4):767-76.

PMID:
15037111
10.

New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents.

Nakajima T, Matsugi T, Goto W, Kageyama M, Mori N, Matsumura Y, Hara H.

Biol Pharm Bull. 2003 Dec;26(12):1691-5.

11.

Endogenous glutamatergic synaptic activity elicits acetylcholine release from rat cultured septal cells.

Suzuki T, Matsugi T, Takagi R, Kawashima K.

Neurosci Res. 2003 Nov;47(3):341-7.

PMID:
14568116
12.

[Effects of ocular hypotensive agents on the circadian rhythm in intraocular pressure in rabbits as measured by telemetry].

Akaishi T, Shimazaki A, Matsugi T, Miyawaki N, Hara H, Kuwayama Y.

Nippon Ganka Gakkai Zasshi. 2003 Sep;107(9):513-8. Japanese.

PMID:
14531310
13.

Living polymerization of ethylene catalyzed by titanium complexes having fluorine-containing phenoxy-imine chelate ligands.

Mitani M, Mohri J, Yoshida Y, Saito J, Ishii S, Tsuru K, Matsui S, Furuyama R, Nakano T, Tanaka H, Kojoh S, Matsugi T, Kashiwa N, Fujita T.

J Am Chem Soc. 2002 Apr 3;124(13):3327-36.

PMID:
11916417
14.

Functional expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors precedes the development of cholinergic phenotype in embryonic rat septal cells in culture.

Suzuki T, Matsugi T, Takagi R, Kanagawa M, Hirata M, Nakamura T, Kudo Y, Kawashima K.

Neurosci Lett. 2001 Sep 28;311(2):89-92.

PMID:
11567785
15.

Adenosine-induced relaxation of cultured bovine retinal pericytes.

Matsugi T, Chen Q, Anderson DR.

Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2695-701.

PMID:
9418721
16.

Contractile responses of cultured bovine retinal pericytes to angiotensin II.

Matsugi T, Chen Q, Anderson DR.

Arch Ophthalmol. 1997 Oct;115(10):1281-5.

PMID:
9338674
17.

Suppression of CO2-induced relaxation of bovine retinal pericytes by angiotensin II.

Matsugi T, Chen Q, Anderson DR.

Invest Ophthalmol Vis Sci. 1997 Mar;38(3):652-7.

PMID:
9071219
18.

The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.

Matsugi T, Kreider BL, Delwel R, Cleveland JL, Askew DS, Ihle JN.

Oncogene. 1995 Jul 6;11(1):191-8.

PMID:
7624127
19.

Selective prostaglandin D2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats.

Matsugi T, Kageyama M, Nishimura K, Giles H, Shirasawa E.

Eur J Pharmacol. 1995 Mar 14;275(3):245-50.

PMID:
7768291
20.

Selective suppression by bunazosin of alpha-adrenergic agonist evoked elevation of intraocular pressure in sympathectomized rabbit eyes.

Nishimura K, Kuwayama Y, Matsugi T, Sun N, Shirasawa E.

Invest Ophthalmol Vis Sci. 1993 Apr;34(5):1761-6.

PMID:
8097189
22.

The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes.

Morishita K, Parganas E, Parham DM, Matsugi T, Ihle JN.

Oncogene. 1990 Sep;5(9):1419-23.

PMID:
1699199
23.

Evidence for the involvement of cyclic GMP in adenosine-induced, age-dependent vasodilatation.

Moritoki H, Matsugi T, Takase H, Ueda H, Tanioka A.

Br J Pharmacol. 1990 Jul;100(3):569-75.

25.

Insertional mutagenesis and transformation of hematopoietic stem cells.

Ihle JN, Morishita K, Matsugi T, Bartholomew C.

Prog Clin Biol Res. 1990;352:329-37.

PMID:
2169632
26.

Phenotypes and mechanisms in the transformation of hematopoietic cells.

Ihle JN, Morishita K, Bartholomew C, Matsugi T, Askew D.

Int J Cell Cloning. 1990 Jan;8 Suppl 1:130-46. Review.

PMID:
2109024
27.

Chromostin, a novel specific inhibitor against reverse transcriptase.

Inouye Y, Manabe N, Mukai H, Nakamura S, Matsugi T, Amanuma H, Ikawa Y.

J Antibiot (Tokyo). 1985 Apr;38(4):519-21. No abstract available.

Supplemental Content

Loading ...
Support Center